Alphagan Combigan — Net revenues
Products & Services · Net revenuesAbbVie Alphagan Combigan — Net revenues increased by 14.9% to $54.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 30.8%, from $78.00M to $54.00M. Over 4 years (FY 2021 to FY 2025), Alphagan Combigan — Net revenues shows a downward trend with a -21.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests sustained market demand or successful lifecycle management of mature ophthalmic products, while a decrease indicates potential market share erosion due to generic competition or shifts in clinical prescribing patterns.
Detailed definition
This metric represents the total net sales generated from the Alphagan and Combigan product lines, which are ophthalmic...
Peer comparison
Comparable to revenue metrics for mature, off-patent, or legacy pharmaceutical product lines in the ophthalmology or specialty care segments of peer companies.
abbv_segment_alphagan_combigan_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $142.00M | $128.00M | $141.00M | $107.00M | $92.00M | $73.00M | $74.00M | $71.00M | $65.00M | $70.00M | $66.00M | $59.00M | $49.00M | $62.00M | $78.00M | $60.00M | $36.00M | $47.00M | $54.00M |
| QoQ Change | — | -9.9% | +10.2% | -24.1% | -14.0% | -20.7% | +1.4% | -4.1% | -8.5% | +7.7% | -5.7% | -10.6% | -16.9% | +26.5% | +25.8% | -23.1% | -40.0% | +30.6% | +14.9% |
| YoY Change | — | — | — | — | -35.2% | -43.0% | -47.5% | -33.6% | -29.3% | -4.1% | -10.8% | -16.9% | -24.6% | -11.4% | +18.2% | +1.7% | -26.5% | -24.2% | -30.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's alphagan combigan — net revenues?
- AbbVie (ABBV) reported alphagan combigan — net revenues of $54.00M in Q4 2025.
- How has AbbVie's alphagan combigan — net revenues changed year-over-year?
- AbbVie's alphagan combigan — net revenues decreased by 30.8% year-over-year, from $78.00M to $54.00M.
- What is the long-term trend for AbbVie's alphagan combigan — net revenues?
- Over 4 years (2021 to 2025), AbbVie's alphagan combigan — net revenues has grown at a -21.9% compound annual growth rate (CAGR), from $529.00M to $197.00M.
- What does alphagan combigan — net revenues mean?
- The total revenue earned from the sale of Alphagan and Combigan eye-care products.